Immunohistochemical Changes After Neoadjuvant Chemotherapy and Their Impact on Breast Cancer Survival: A Systematic Review and Meta-analysis
OncologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Clinical breast cancer
- Publicado em
- 1 nov 2025
- Citações
- 4
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Immunohistochemical Changes After Neoadjuvant Chemotherapy and Their Impact on Breast Cancer Survival: A Systematic Review and Meta-analysis
Marcelo Antonini, André Mattar, Gil Facina, Francisco Pimentel Cavalcante, Felipe Zerwes, Fabricio Palermo Brenelli, Antonio Luis Frasson, Eduardo Camargo Millen, Rodrigo Caires Campos, Letícia Xavier Félix et al.
Descritores MeSH
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
- Biomarkers, Tumor
- Neoadjuvant Therapy
- Immunohistochemistry
- Prognosis
- Receptors, Estrogen
- Receptors, Progesterone
- Erb-b2 Receptor Tyrosine Kinases
- Chemotherapy, Adjuvant
Veja também
Estudos relacionados
- On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer
- Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial
- Prognostic significance of receptor conversion following neoadjuvant therapy in breast cancer: a systematic review & meta-analysis
- Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914)